R-Tech Ueno starts phase III of retina pigmentary degeneration drug candidate UF-021

R-Tech Ueno results briefing, Nov. 15, 2012

R-Tech Ueno starts phase III of retina pigmentary degeneration drug candidate UF-021
Scroll to top